In addition to these results within solid tumor models, a recent study also showed beneficial effects of anti-RSPO3 treatment in certain acute myeloid leukemia PDX models, where anti-RSPO3 treatment effectively inhibited leukemia stem cells without harming healthy stem cells [153]. This evidence concerns the gene RSPO3 and acute myeloid leukemia.